Microparticle silver chloride chitosan and moringa leaf deodorant alternative
A novel deodorant formulation using microparticle silver chloride chitosan and Moringa leaf powder to replace alum, offering odor elimination and moisture absorption. Proven non-toxic and safe for human skin, it targets odor-causing bacteria without irritation.
Overview
Chitozan Health LLC introduces a cutting-edge deodorant solution that leverages a patented microparticle silver chloride chitosan combined with Moringa leaf powder. This innovative formulation aims to replace traditional alum-based deodorants by effectively eliminating odor-causing bacteria while absorbing moisture. The use of low molecular weight chitosan ensures a non-toxic and allergen-free composition, making it safe for human skin. This solution is designed to provide a natural and effective alternative to conventional deodorants.
Technical specifications
- Composition: Patented microparticle silver chloride chitosan with Moringa leaf powder.
- Particle Size: Silver particles range from 150 to 350nm, above the nanoparticle range.
- Safety: Proven non-toxic, non-irritant, and does not cause dermal sensitization, having passed the EPA 6-pack safety assessments.
- Applications: Can be formulated into various forms such as sprays, roll-ons, or dry cakes, making it versatile for consumer preferences.
Technology readiness level
This technology is currently at TRL 4, indicating it has been validated in a laboratory setting. Future collaboration with product development teams is planned to optimize absorption rates, application methods, and to provide technical support for further development.
About Chitozan Health LLC
Chitozan Health LLC is a biotechnology research firm that develops antimicrobial solutions utilizing patented silver-chitosan technology [1][3][5]. Their core innovation, marketed as Silver Shell or Glucosil, incorporates chitosan and silver particles to create durable, effective antimicrobial barriers for various applications [1][5][8]. By leveraging the biostatic properties of chitosan, the company produces textile finishes and topical gels that are designed to combat pathogens, including bacteria, fungi, and viruses, while minimizing the use of silver and maintaining safety standards [1][5][8]. This research is supported by NIH NIAID funding and focuses on managing infections, such as those related to Pseudomonas aeruginosa in cystic fibrosis, as well as providing broad-spectrum protection in healthcare and consumer settings [1][5][7].
These products serve a range of stakeholders, from industrial partners in textile manufacturing and sustainable packaging to healthcare providers and individual consumers in need of advanced wound and burn care [1][4][7][8]. The company's technology addresses critical challenges such as antimicrobial resistance, infection control, and the environmental impact of synthetic materials [1][4][8]. Through rigorous independent laboratory testing, their treatments have demonstrated significant efficacy in reducing pathogen populations and sustaining performance even after multiple commercial wash cycles [1][5]. With a focus on sustainable, naturally derived materials, Chitozan Health aims to provide safer, more effective alternatives for infection mitigation across multiple sectors [1][7].
delivered to your inbox.